Kevin Hay

Hematologist, Leukemia / Bone Marrow Transplant Program of BC; Assistant Medical Director, Clinical Cell Therapy
Degrees / Designations 


MD (Medicine), University of Manitoba, 2007 – 2011

MSc (Immunology), University of Manitoba, 2005 – 2018

BSc (Biology (Honors) and Chemistry), Trinity Western University, 1999 – 2005

Post-Graduate Training

Postdoctoral Research Fellow, Cellular Immunotherapy,

Fred Hutchinson Cancer Research Center, 2016 – 2018

Clinical Investigator Program Fellow in Cellular Immunotherapy,

University of British Columbia, 2016 – 2018

Hematology Fellow, University of British Columbia, 2014 – 2014

Internal Medicine Resident, University of British Columbia, 2011 – 2014

Email Address 
Mailing Address 
Rm. 13.112, Terry Fox Laboratory BC Cancer Research Centre 675 West 10th Avenue Vancouver, British Columbia V5Z 1L3


Academic Appointment 
Assistant Professor
Body Locations and Systems 
Immune System
Disorders and Conditions 
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diagnosis and Therapy 
Transplantation and Donation
Other Areas of Research 
Cell Therapy

Dr. Kevin Hay is a Clinician Scientist at the Terry Fox Laboratory and Leukemia/Bone Marrow Transplant Program of BC in Vancouver. Dr. Hay received a Master of Science in Immunology at the University of Manitoba (2008), followed by an MD (2011). After completing residency in Internal Medicine (2014) and a clinical fellowship in Haematology (2016) at the University of British Columbia, he was awarded a scholarship through the Clinician Investigator Program of UBC to pursue a postdoctoral fellowship in cellular immunotherapy which he completed at the Fred Hutchinson Cancer Research Center in Seattle Washington under the mentorship of Dr. Cameron Turtle. Dr. Hay’s research focuses on understanding the unique toxicities associated with chimeric antigen receptor T (CAR-T) cells, as well as the development of novel CAR-T cell therapies.